Congress presented developments in gynecological cancers treatment, highlighting clinical trial outcomes and emerging strategies.
The European Society for Medical Oncology Gynaecological Cancers Congress 2025, held in Vienna from June 19 to 21, brought together over 1150 participants from 82 countries to discuss recent advances in the management of gynecological cancers. With 17 scientific sessions and 126 abstract presentations, the congress served as a key platform for presenting innovations in the treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers. This paper highlights and analyzes the most relevant studies presented, focusing on emerging treatment strategies, clinical trial outcomes, and translational research. By critically examining these contributions, we aim to provide a concise overview of the evolving landscape of gynecologic oncology and its implications for clinical practice.
No takes yet. Share an insight, caveat, or question.
Leis et al. (2025) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: